Eli Lilly Corp. buy Guggenheim
Start price
20.01.26
/
50%
€881.00
Target price
20.01.27
€997.30
Performance (%)
-12.38%
Price
16:59
€771.90
Summary
This prediction is currently active. The prediction for Eli Lilly Corp. disappoints with a performance of -12.38%. This prediction currently runs until 20.01.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | -1.566% | -1.566% |
| iShares Core DAX® | -1,74 % | -10,68 % |
| iShares Nasdaq 100 | -2,58 % | -3,32 % |
| iShares Nikkei 225® | -1,16 % | -9,36 % |
| iShares S&P 500 | -1,42 % | -3,76 % |
Comments by Guggenheim for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE:LLY) had its price target lowered by analysts at Guggenheim from $1,163.00 to $1,161.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
Stopped prediction by Guggenheim for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€844.20
16.08.24
16.08.24
€935.65
16.08.25
16.08.25
-28.93%
17.08.25
17.08.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€706.60
05.08.24
05.08.24
€806.83
05.08.25
05.08.25
-6.30%
06.08.25
06.08.25